Interesting New Drug of Note

You can find out about this drug and a few others that are new, at the evolve textbook pharmacology website. Once in the pharm site, click on course material, then Lehne's Pharmacology for nursing care updates, then Vol. 5.1 February 2005. This drug and others are part of the drug families in which we are being tested on, Monday.
Daptomycin [Cubicin], the first cyclic lipopeptide. It is the first representative of a new class of antibiotics, the cyclic lipopeptides. The drug has a unique mechanism of action and can rapidly kill virtually all clinically relevant gram-positive bacteria, including methicillin-resistant staphylococcus aureus. It is devoid of significant drug interactions, and the only side effect of note is possible muscle injury. The drug is given once a day by IV infusion, and there is no need to monitor it's plasma level.